Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide (Q58030111)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 April 2011

Language	Label	Description	Also known as
English	Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide	scientific article published on 30 April 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

(RS)-lenalidomide

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giovanni Palladini

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Francesca Lavatelli

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Giampaolo Merlini

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Paola Russo

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Andrea Foli

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Silvia Brugnatelli

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Rosangela Invernizzi

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

30 April 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Annals of Hematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

91

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

89-92

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Dangerous small B-cell clones.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1244-X

21 January 2018

Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1244-X

21 January 2018

Transplantation vs. conventional-dose therapy for amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1244-X

21 January 2018

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1244-X

21 January 2018

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1244-X

21 January 2018

Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1244-X

21 January 2018

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1244-X

21 January 2018

The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1244-X

21 January 2018

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1244-X

21 January 2018

Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1244-X

21 January 2018

Kidney dysfunction during lenalidomide treatment for AL amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1244-X

21 January 2018

Identifiers

10.1007/S00277-011-1244-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533608%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58030111&oldid=2118413988"